News & Blogs

Commitment to Seniors Urges the U.S. Senate to Oppose any Inclusion of the “Most Favored Nation” Drug Pricing Model in Vote-A-Rama

Washington, D.C. – May 20, 2026 Commitment to Seniors (C2S), a project of American Commitment urges the U.S. Senate to oppose any effort to include the “Most Favored Nation” (MFN) drug pricing model in the upcoming vote-a-rama on Reconciliation 3.0. This foreign price-fixing policy could have a devastating impact on the prescription drug market millions of older Americans rely upon.

MFN would import foreign price controls by tying U.S. drug prices to those set by other countries, many of which operate government-run health care systems. Not only is this bad policy, but it’s the wrong response to addressing foreign freeloading on American biomedical innovation. In fact, embracing an MFN model would worsen that trade imbalance. Instead, the United States should address these unfair practices through bold trade negotiations that hold other countries accountable for paying their fair share.

Furthermore, an MFN model would put American jobs at risk and undermine our global leadership in medial innovation, particularly as China continues investing aggressively in biotechnology and pharmaceutical development. Today, the United States leads the world in R&D for lifesaving treatments, including for cancer, Alzheimer’s disease, and chronic conditions that disproportionately affect seniors. Tying U.S. prices to foreign benchmarks would jeopardize investment in breakthrough therapies and weaken America’s competitive edge in health care innovation.

Seniors deserve reforms that protect access to medicines, strengthen innovation, and preserve American jobs. An MFN pricing model would accomplish the opposite.

“As the Senate prepares for its upcoming vote-a-rama, I respectfully urge you to reject any effort to include MFN in the reconciliation package,” said Phil Kerpen, President of American Commitment. “Rather than imposing additional price controls, Congress should prioritize alternative solutions to strengthen America’s health care system, such as demanding that foreign countries pay their fair share for U.S. innovation and ending the PBM kickback scheme to deliver real savings to seniors.”